OKUR — OnKure Therapeutics, Inc. Dilution Risk Tracker

OnKure Therapeutics, Inc. (OKUR) has a DilutionScore of 53/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

The most significant dilution vector for OKUR is its shelf registration capacity of $150.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. DilutionWatch tracks 9.4M outstanding warrants for OKUR. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for OKUR in real-time, scanning EDGAR every 60 seconds. A recent S-3 or registration statement filing appears in OKUR's filing history — this warrants monitoring for subsequent prospectus supplements (Form 424B), which indicate active capital raising. The DilutionWatch screener shows real-time score changes for OKUR alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.